EX-10.1
from 8-K
12 pages
The Undersigned Understands That BioCorRx Inc., a Corporation Organized Under the Laws of Nevada (The “Company”), Desired to Sell Shares of Its Common Stock, Par Value $0.001 Per Share (The “Securities”), at a Purchase Price of $4.35 Per Share (The “Purchase Price”). the Undersigned Further Understands That the Securities Will Not Be Registered Under the Securities Act of 1933, as Amended (The “Securities Act”), or Any Securities Law of Any State of the United States or of Any Other Jurisdiction, in Reliance Upon the Exemption From Securities Registration Afforded by Section 4(a)(2) of the Securities Act of 1933, as Amended (The “Securities Act”), or Rule 506 of Regulation D of as Promulgated by the Securities and Exchange Commission (The “SEC”), Under the Securities Act, or Regulation S, as Promulgated by the SEC Under the Securities Act
12/34/56
EX-10.1
from 8-K
10 pages
The Undersigned Understands That BioCorRx Inc., a Corporation Organized Under the Laws of Nevada (The “Company”), Desired to Sell Shares of Its Common Stock, Par Value $0.001 Per Share (The “Securities”), at a Purchase Price of $2.00 Per Share (The “Purchase Price”). the Undersigned Further Understands That the Securities Will Not Be Registered Under the Securities Act of 1933, as Amended (The “Securities Act”), or Any Securities Law of Any State of the United States or of Any Other Jurisdiction, in Reliance Upon the Exemption From Securities Registration Afforded by Section 4(a)(2) of the Securities Act of 1933, as Amended (The “Securities Act”), or Rule 506 of Regulation D of as Promulgated by the Securities and Exchange Commission (The “SEC”), Under the Securities Act, or Regulation S, as Promulgated by the SEC Under the Securities Act
12/34/56